| Literature DB >> 33782903 |
Valeria Hasenmajer1, Giulia Puliani2,3, Marianna Minnetti2, Emilia Sbardella2, Claudio M Mastroianni4, Gabriella D'Ettorre4, Andrea M Isidori2, Daniele Gianfrilli2.
Abstract
Parathyroid disorders are characterized by alterations in calcium and phosphate homeostasis due to inappropriately high or low levels of parathyroid hormone (PTH). Despite PTH receptor type 1 has been described in almost all immune lineages and calcium signalling has been confirmed as a crucial mediator for immune response, in vitro studies on the physiological interactions between PTH and immunity are conflicting and not representative of the clinical scenarios seen in patients with parathyroid disorders. Infectious diseases are among the main causes of increased morbidity and mortality in patients with secondary hyperparathyroidism and chronic kidney disease. More, immune alterations have been described in primary hyperparathyroidism. Recent studies have unveiled an increased risk of infections also in hypoparathyroidism, suggesting that not only calcium, but also physiological levels of PTH may be necessary for a proper immune response. Finally, calcium/phosphate imbalance could affect negatively the prognosis of infectious diseases. Our review aimed to collect available data on infectious disease prevalence in patients with parathyroid disorders and new evidence on the role of PTH and calcium in determining the increased risk of infections observed in these patients.Entities:
Keywords: Hyperparathyroidism; Hypoparathyroidism; Immune function; Infectious disease; PTH
Mesh:
Substances:
Year: 2022 PMID: 33782903 DOI: 10.1007/5584_2021_629
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622